Found 192 matching trials
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues EARLY_PHASE1 This study is for people who have multiple sclerosis, acute leukemia (in re...
Show More Location
University of Chicago Medicine Comprehensive Cancer Center
Learn More & Join Trial
The Effect of Liraglutide on the GIT PHASE4 Liraglutide is a glucose-like peptide 1 agonist, currently used as an effec...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of LY3025876 in Participants With Diabetes PHASE1 The main purpose of this study is to assess the safety and tolerability of ...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Comparison of Two Liraglutide Formulations in Healthy Volunteers PHASE1 This trial is conducted in Europe. The aim of this trial is to test for bio...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Incretin-based Therapy in Late Preclinical Type 1 Diabetes PHASE2 The objective of the trial is to study whether daily treatment with liraglu...
Show More Location
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents
Learn More & Join Trial
Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers PHASE1 This trial is conducted in Europe. the aim of this trial is to compare the ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome PHASE4 The purpose of this study was to determine whether monotherapy treatment wi...
Show More Location
University Medical Center Ljubljana
Learn More & Join Trial
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND) PHASE4 BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Show More Location
Unit of Endocrinology and Metabolic Diseases
Learn More & Join Trial
Liraglutide Treatment to Patients With Severe Renal Insufficiency PHASE4 Incretin-based therapy for the treatment of patients with type 2 diabetes m...
Show More Location
Department of Endocrinology PE, Copenhagen University Hospital, Rigshospitalet
Learn More & Join Trial
Incretin Effect on the Immunological Phenotype PHASE2 Assessment of the effect of incretin based therapies (Liraglutide and Saxag...
Show More Location
Medical University Graz
Learn More & Join Trial